Immunology Program

The Michael Glickman Lab

Share
Back to top

Research

Michael Glickman
Michael S. Glickman, MD

We are broadly interested in the biology of mycobacteria, which include the major human pathogen M. tuberculosis, the nonpathogenic model organism M. smegmatis, and the cancer biotherapeutic agent BCG.

View Lab Overview

Research Projects

Michael Glickman Lab

Featured News

Michael Glickman
At Work: Infectious Diseases Specialist Michael Glickman

Physician-scientist Michael Glickman cares for cancer patients who have infections. In his laboratory, he aims to understand how infections develop.
SKI immunologist Michael Glickman
MSK Scientists Solve One of TB’s Deadliest Tricks

Scientists at Memorial Sloan Kettering have pieced together the biochemical mechanism by which the tuberculosis bacterium sneaks past our immune defenses.
MSK physician-scientists Michael Glickman and Gil Redelman-Sidi
The ABCs of BCG: Oldest Approved Immunotherapy Gets New Explanation

BCG has been used to treat bladder cancer for more than 30 years. Scientists are still learning how it works.

People

Michael Glickman

Michael S. Glickman, MD

  • Physician-scientist Michael Glickman investigates the physiology and pathogenic mechanisms of mycobacteria, including the use of mycobacteria as bacterial cancer therapies.
  • MD, Columbia University College of Physicians and Surgeons
[email protected]
Email Address
646-888-2368
Office Phone
View physician profile
Physician profile

Members

Michael Glickman, MD
Michael Glickman

Member

John Buglino, PhD
John Buglino

Senior Research Scientist

Allison Fay, PhD
Allison Fay

Senior Research Scientist

Gil Redelman-Sidi, MD
Gil Redelman-Sidi

Assistant Attending Physician

Jamie Bean
Jamie Bean

Assistant Lab Member, EIO Cell Bank director

Anna Binyamin

Lab Manager

Muxue Du
Muxue Du

Research Technician

Song Jiang
Song Jiang

Fellow

Shireen Khayat

Graduate Student

Adam Krebs
Adam Krebs

Graduate Student

Yaprak Ozakman
Yaprak Ozakman

Research Scholar

Gaurav Sankhe
Gaurav Sankhe

Research Associate

Pablo Santos Molina
Pablo Santos Molina

MSK Bridge Program Scholar

Veronica Shields

Administrative Assistant

Lab Alumni
Hitesh Bhattarai
Hitesh Bhattarai

Graduate Student

Richa Gupta, PhD
Richa Gupta

Research Fellow

Kendra Harris
Kendra Harris

Graduate Student

Brook Heaton

Research Scholar

Nathaniel Lazar

Graduate Student

Shilpa Reddy
Shilpa Reddy

Research Technician

Jessica Schneider
Jessica Schneider

Graduate Student

Han-guang Yan
Han-guang Yan

Senior Research Technician

Oyindamola Adefisayo, BA
Oyindamola Adefisayo

Graduate Student

Anthony Antonelli
Anthony Antonelli

Research Fellow

Pierre Dupuy
Pierre Dupuy

Research Fellow

Olivier Levy, PhD
Olivier Levy

Postdoctoral Fellow

Bernadette Lynn

Technician

Ashta Nautiyal
Ashta Nautiyal
Miroslav Skular
Miroslav Skular

Research Technician

Dave van Ditmarsch, PhD
Dave van Ditmarsch

Research Associate

Charles Vorkas, MD
Charles Vorkas

ID fellow

Matthew Wipperman, Ph.D., M.Sc
Matthew Wipperman

Postdoctoral Fellow

Nicolas Stephanou
Daniel Barkan

Fellow

Vivek Rao
Hideki Makinoshima
Feng Gao
Pratima Kunwar
Paola Bongiorno
Jideofer Aniukwu
Linda Chu
Christina Stallings
Hock-Yong E
Joseph Sklar, PhD
Joseph Sklar

Research Fellow

Lab Affiliations

Get in Touch

Disclosures

Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

Michael S. Glickman discloses the following relationships and financial interests:

  • Fimbrion Therapeutics, Inc.
    Provision of Services
  • Opentrons Labworks Inc.
    Provision of Services
  • Vedanta
    Ownership / Equity Interests; Provision of Services

The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.

This page and data include information for a specific MSK annual disclosure period (January 1, 2021 through disclosure submission in spring 2022). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].


View all disclosures

Related topics: